InvestorsHub Logo
Followers 105
Posts 20514
Boards Moderated 0
Alias Born 06/30/2012

Re: None

Tuesday, 12/06/2016 10:56:10 PM

Tuesday, December 06, 2016 10:56:10 PM

Post# of 20617
Another great point/post...this time by Tony over on Yahoo...

"Novalere is taking a big if not bigger risk, if Fluticare was to be rejected they would be locked in until Q2 unable to sell, while INNV sinks like a stone, unless there is a clause in that 10Q that states otherwise (I'll have to look into that)... Either way, it seems like both companies are very confident in a near term approval."


** Never looked at it from this perspective...If Novalere is truly locked up until 4/1/17 by taking those ANDA shares early - think of the chance THEY are taking, if it was denied.

Logically thinking this through Tony is right - BOTH companies have to be pretty darn confident here that it WILL BE APPROVED fairly soon. The risk/reward ratio is leaning more towards UPSIDE IMO with BH platform and new products doing so well. GLTA
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.